Madison-based Children's Wisconsin and UW Health have entered into a joint venture that merges their congenital heart disease programs, according to a Dec. 12 report from the Milwaukee Journal ...
Discover the inspiring story of the Fontan Choir, a choir of children with congenital heart conditions, who are improving their lung function through singing.
Mesoblast’s Revascor gets US FDA’s regenerative medicine advanced therapy designation in children with congenital heart disease: New York Friday, December 6, 2024, 18:00 Hrs [ ...
FDA granted REVASCOR both Rare Pediatric Disease Designation (RPDD) and Orphan-Drug Designation (ODD) for congenital heart disease. NEW YORK, Dec. 04, 2024 (GLOB ...